The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
8-(4-(2-(4-(3-(Trifluoromethyl)phenyl)piperidin-1-yl)ethyl)-1H-pyrazol-1-yl)pyrido[3,4-d]pyrimidin-4(3H)-one ID: ALA3775548
PubChem CID: 137175122
Max Phase: Preclinical
Molecular Formula: C24H23F3N6O
Molecular Weight: 468.48
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=c1[nH]cnc2c(-n3cc(CCN4CCC(c5cccc(C(F)(F)F)c5)CC4)cn3)nccc12
Standard InChI: InChI=1S/C24H23F3N6O/c25-24(26,27)19-3-1-2-18(12-19)17-6-10-32(11-7-17)9-5-16-13-31-33(14-16)22-21-20(4-8-28-22)23(34)30-15-29-21/h1-4,8,12-15,17H,5-7,9-11H2,(H,29,30,34)
Standard InChI Key: ZBLHURFMYIWFIY-UHFFFAOYSA-N
Molfile:
RDKit 2D
34 38 0 0 0 0 0 0 0 0999 V2000
-2.6111 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 1.4973 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 -0.7486 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 0.7486 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2928 -2.6973 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 2.9980 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0843 3.8599 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.5502 5.2857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0502 5.2832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5114 3.8559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9354 6.4920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4275 6.3306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3141 7.5414 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.8057 7.3822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6894 8.5943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0816 9.9656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5901 10.1249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7064 8.9129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9658 11.1782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4577 11.0214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3395 12.2348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7295 13.6052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2377 13.7622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3559 12.5487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6274 15.1333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3322 16.1045 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.4340 15.2585 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
7.1389 16.2294 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 1 0
1 6 1 0
8 9 2 0
9 10 1 0
7 10 2 0
3 7 1 0
4 8 1 0
5 11 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
12 16 1 0
17 18 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
19 24 1 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 30 1 0
25 30 2 0
22 25 1 0
18 19 1 0
15 17 1 0
7 12 1 0
31 32 1 0
31 33 1 0
31 34 1 0
29 31 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 468.48Molecular Weight (Monoisotopic): 468.1885AlogP: 3.94#Rotatable Bonds: 5Polar Surface Area: 79.70Molecular Species: BASEHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.07CX Basic pKa: 9.00CX LogP: 3.28CX LogD: 1.92Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.48Np Likeness Score: -1.45
References 1. Bavetsias V, Lanigan RM, Ruda GF, Atrash B, McLaughlin MG, Tumber A, Mok NY, Le Bihan YV, Dempster S, Boxall KJ, Jeganathan F, Hatch SB, Savitsky P, Velupillai S, Krojer T, England KS, Sejberg J, Thai C, Donovan A, Pal A, Scozzafava G, Bennett JM, Kawamura A, Johansson C, Szykowska A, Gileadi C, Burgess-Brown NA, von Delft F, Oppermann U, Walters Z, Shipley J, Raynaud FI, Westaway SM, Prinjha RK, Fedorov O, Burke R, Schofield CJ, Westwood IM, Bountra C, Müller S, van Montfort RL, Brennan PE, Blagg J.. (2016) 8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase Inhibitors., 59 (4): [PMID:26741168 ] [10.1021/acs.jmedchem.5b01635 ]